|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Accounts receivable, net of allowance of doubtful accounts of $5,109 and $5,159, respectively | ||||||||||||
| Inventory, net | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Right-of-use asset | ||||||||||||
| Other long-term assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and Stockholders' Deficit | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Current portion of term loan | ||||||||||||
| Current portion of lease liabilities | ||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||
| Current portion of convertible notes payable | ||||||||||||
| Total current liabilities | ||||||||||||
| Warrant liabilities | ||||||||||||
| Revenue Interest Financing liability | ||||||||||||
| Earn-out liabilities | ||||||||||||
| Convertible notes payable | ||||||||||||
| Lease liabilities, net of current portion | ||||||||||||
| Other liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Legacy convertible preferred stock (Note 12) | ||||||||||||
| Series A redeemable convertible preferred stock, $0.0001 par value - 100,000,000 shares authorized as of September 30, 2024; and 2,260,159 and zero shares issued and outstanding as of September 30, 2024 and December 31, 2023 | ||||||||||||
| Stockholders' deficit: | ||||||||||||
| Convertible preferred stock (Series A, A-1, B, D-1, D-2, D-3), $0.0001 par value;12,916,272 shares authorized; 11,988,508 and 11,984,370 shares issued and outstanding; redemption and liquidation value of $91,975 and $90,539 as of June 30,2023 and December 31, 2022, respectively | ||||||||||||
| Common stock, $0.0001 par value - 1,000,000,000 shares authorized as of March 31, 2026; 14,994,486 and 12,279,181 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive gain (loss) | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' deficit | ||||||||||||
| Total liabilities and stockholders' deficit |
Loading...
